AU2024901805A0 - Air Puff Device to Treat Meibomian Gland Deficiencies - Google Patents

Air Puff Device to Treat Meibomian Gland Deficiencies

Info

Publication number
AU2024901805A0
AU2024901805A0 AU2024901805A AU2024901805A AU2024901805A0 AU 2024901805 A0 AU2024901805 A0 AU 2024901805A0 AU 2024901805 A AU2024901805 A AU 2024901805A AU 2024901805 A AU2024901805 A AU 2024901805A AU 2024901805 A0 AU2024901805 A0 AU 2024901805A0
Authority
AU
Australia
Prior art keywords
meibomian gland
air puff
puff device
treat meibomian
deficiencies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2024901805A
Inventor
Klaus Ehrmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nthalmic Holding Pty Ltd
Zhong Jing Wei Shi Suzhou Optical Technology Ltd
Original Assignee
Nthalmic Holding Pty Ltd
Zhong Jing Wei Shi Suzhou Optical Technology Ltd
Filing date
Publication date
Application filed by Nthalmic Holding Pty Ltd, Zhong Jing Wei Shi Suzhou Optical Technology Ltd filed Critical Nthalmic Holding Pty Ltd
Publication of AU2024901805A0 publication Critical patent/AU2024901805A0/en
Pending legal-status Critical Current

Links

AU2024901805A 2024-06-14 Air Puff Device to Treat Meibomian Gland Deficiencies Pending AU2024901805A0 (en)

Publications (1)

Publication Number Publication Date
AU2024901805A0 true AU2024901805A0 (en) 2024-06-27

Family

ID=

Similar Documents

Publication Publication Date Title
EP4153111A4 (en) Methods and apparatus to manage meibomian gland deficiencies
AU2016202421B2 (en) Method of treating neurological conditions with cardiac glycosides
NZ599605A (en) Hemostatic compositions and therapeutic regimens
EA200800538A1 (en) THERAPEUTIC CONNECTIONS
AU2024902869A0 (en) Air puff device to treat meibomian gland deficiencies
AU2024901805A0 (en) Air Puff Device to Treat Meibomian Gland Deficiencies
NZ700818A (en) Compounds as modulators of a mutant cftr protein and their use for treating diseases associated with cftr protein malfunction
CL2021000176A1 (en) Use of gram negative species to treat atopic dermatitis
WO2010107251A3 (en) Pharmaceutical composition used in prophylaxis or treatment of hyperproliferative skin conditions and malignant melanomas comprising pachastrissamine as active ingredient
EP4097236A4 (en) Compositions and methods to treat neurological diseases
AU2024901939A0 (en) Smart Wearable Device To Treat Meibomian Gland Deficiencies
AU2024900825A0 (en) Smart Wearable Device To Treat Meibomian Gland Deficiencies
AU2020901615A0 (en) Wearable fabric to treat meibomian gland deficiencies
EP4110446A4 (en) Improvements relating to provision of gas-flow
EP4153208A4 (en) Compositions and methods relating to aging skin
EP4096704A4 (en) Therapeutic uses of dulaglutide
WO2020228845A3 (en) Sound insulation and noise reduction apparatus
EP3908370A4 (en) Use of photobiomodulation therapy to treat inflammatory and/or metabolic conditions
MX2016003650A (en) Prostaglandin f2alpha and analogues thereof for treating atrophic cutaneous scarring.
GB2611766B (en) Ultrsonic probe to improve absorption of active ingredients into the skin
CN104721073A (en) Shower gel
EP4138916A4 (en) Novel therapy for acute damage to lung tissue
MX2012003865A (en) TOPICAL COMPOSITIONS CONTAINING <i>DERRIS SCANDENS BENTH</i>. AND A METHOD OF TREATING SKIN.
MX2022004339A (en) Fractionated dosing of a phospholipid ether analog for the treatment of cancer.
AU2023902298A0 (en) Human to Robot Teleporter Device